Herpes Zoster Infections in SLE in a University Hospital in Saudi Arabia: Risk Factors and Outcomes

scientific article

Herpes Zoster Infections in SLE in a University Hospital in Saudi Arabia: Risk Factors and Outcomes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4061/2010/174891
P932PMC publication ID2989732
P698PubMed publication ID21152215
P5875ResearchGate publication ID49677907

P2093author name stringA S Al Arfaj
Afsar Sayeeda
Najma Khalil
Hussain Al Arfaj
P2860cites workDerivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.Q44441787
Virus antibody levels in systemic lupus erythematosusQ45820606
Reinfection with varicella-zoster virus in immunocompromised patientsQ45843354
Abnormalities of delayed hypersensitivity in systemic lupus erythematosusQ47964966
Herpes zoster at the NIH: A 20 year experienceQ67027342
Herpes zoster in patients with systemic lupus erythematosusQ67389210
Herpes Zoster-Varicella infections and lymphomaQ68637024
Lupus erythematosus and herpes zosterQ69925179
Herpes zoster in systemic lupus erythematosusQ71750903
Population-based study of herpes zoster and its sequelaeQ72112939
Herpes zoster infections in systemic lupus erythematosus: risk factors and outcomeQ33492486
High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysisQ33562897
Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infectionsQ34088091
NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and preventionQ34681071
Herpes zoster in juvenile-onset systemic lupus erythematosus: incidence, clinical characteristics and risk factors.Q36549594
Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigenQ37038155
Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients.Q37471544
Herpesvirus infections in the immunocompromised host. Clinical spectrum, diagnosis, management and prophylaxisQ38277966
Varicella-zoster infection in adult cancer patients. A population studyQ39712266
Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virusQ40108192
NIH conference. Herpes zoster-varicella infections in immunosuppressed patientsQ40169164
Systemic lupus erythematosus and infections: a retrospective study in SaudisQ40440734
CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES.Q40971202
Prolonged Herpes-Zoster Infection Associated with Immunosuppressive TherapyQ41141268
Selective decline in cellular immune response to varicella-zoster in the elderlyQ41548624
Depression of cellular-mediated immunity in systemic lupus erythematosus. relation to disease activityQ41840807
Latent varicella-zoster viral DNA in human trigeminal and thoracic gangliaQ43982219
P275copyright licenseCreative Commons Attribution 3.0 UnportedQ14947546
P6216copyright statuscopyrightedQ50423863
P921main subjectSaudi ArabiaQ851
herpes zosterQ182155
P304page(s)174891
P577publication date2010-09-13
P1433published inAutoimmune DiseasesQ26842451
P1476titleHerpes Zoster Infections in SLE in a University Hospital in Saudi Arabia: Risk Factors and Outcomes
P478volume2011

Reverse relations

cites work (P2860)
Q90697238From Severe Herpes Zoster to Rare Suid Herpesvirus Encephalitis: A New Twist of the Varicellovirus Genus Infection in Patients with Kidney Diseases
Q36831124Herpes Zoster as the Presenting Manifestation of Systemic Lupus Erythematosus (SLE): A Rare Case Report
Q47139465Herpes zoster in patients with systemic lupus erythematosus: Clinical features, complications and risk factors
Q37634514The case for Zostavax vaccination in systemic lupus erythematosus

Search more.